glp-1 compounding crackdown news october 2025 FDA proposes a new The FDA is proposing the

These medications mimic the bodys natural GLP-1 hormone, helping you feel full longer and eat less without constant hunger

Rybelsus Rybelsus, another semaglutide drug made by Novo Nordisk, is an oral GLP-1 receptor agonist prescribed to treat type 2 diabetes

A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1

At a monthly cost of approximately INR 14,000 to INR 17,500 (around $168 to $210), the drugs remain out of reach for most of the countrys population, even as India accounts for nearly 101 million people living with diabetes